- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: XTANDI
Total 189 results
-
PfizerAstellas Pharma IncActive, not recruitingProstatic Neoplasms, Castration-ResistantUnited States
-
Santa Chiara HospitalCompletedProstatic NeoplasmsItaly
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Eli Lilly and CompanyActive, not recruiting
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Novartis; Prostate Cancer Clinical Trials ConsortiumCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7 | Prostate Carcinoma Metastatic in the BoneUnited States
-
University of California, DavisNational Cancer Institute (NCI); Astellas Pharma Inc; Medivation, Inc.Active, not recruitingEnzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate CancerProstate CancerUnited States
-
University of Colorado, DenverActive, not recruitingRecurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast CancerUnited States, Spain, Belgium, Canada, Italy, Ireland, United Kingdom
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.Active, not recruiting
-
Zenith EpigeneticsEnrolling by invitation
-
Medical College of WisconsinActive, not recruiting
-
Instituto do Cancer do Estado de São PauloAstellas Pharma IncActive, not recruitingProstate Cancer | Castration-resistant Prostate CancerBrazil
-
Astellas Pharma Europe Ltd.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration Resistant Prostate CancerBelgium, France, Spain, Austria, Czechia, Germany, Greece, Italy, Netherlands, Norway, Poland, Russian Federation, Sweden, Switzerland, Turkey, United Kingdom
-
Astellas Pharma IncCompletedMetastatic Castration Resistant Prostate CancerIndia
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate CancerCanada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
-
OHSU Knight Cancer InstituteAstellas Pharma US, Inc.; Oregon Health and Science UniversityActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
pharmaand GmbHFoundation MedicineActive, not recruitingMetastatic Castration Resistant Prostate CancerUnited States, Canada, Spain, France, Australia, Ireland, Belgium, Denmark, United Kingdom, Germany, Israel, Italy
-
PfizerAstellas Pharma IncActive, not recruiting
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityTerminatedPrimary Myelofibrosis | Anemia | Recurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic... and other conditionsUnited States
-
MedSIRPfizerActive, not recruitingMetastatic Prostate CancerSpain
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
OHSU Knight Cancer InstituteMerck Sharp & Dohme LLC; Oregon Health and Science University; Collins Medical...Active, not recruitingCastration-Resistant Prostate Carcinoma | Recurrent Prostate Carcinoma | PSA Progression | Hormone-Resistant Prostate Cancer | Stage IV Prostate Adenocarcinoma Cancer AJCC v8United States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy
-
Australian and New Zealand Urogenital and Prostate...Astellas Pharma Inc; Endocyte; Prostate Cancer Research Alliance; National Health...Active, not recruitingMetastatic Castration-Resistant Prostate CancerAustralia
-
RTOG Foundation, Inc.Pfizer; Astellas Pharma IncActive, not recruitingProstate CancerUnited States, Canada
-
Veru Inc.TerminatedMetastatic Castration-resistant Prostate Cancer | Androgen Resistant Prostatic CancerUnited States
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom, New Zealand
-
University of Michigan Rogel Cancer CenterTerminatedProstate CancerUnited States
-
Wake Forest University Health SciencesAstellas Pharma Inc; Medivation, Inc.Active, not recruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast... and other conditionsUnited States
-
Astellas Pharma China, Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerChina
-
Merck Sharp & Dohme LLCActive, not recruitingProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom, Bulgaria, Czechia, Hu... and more
-
ORIC PharmaceuticalsTerminated
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedInvasive Breast Carcinoma | Triple-Negative Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer | Prostate Carcinoma Metastatic in the BoneUnited States
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate Cancer (CRPC)United States, Moldova, Republic of, South Africa
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Recurrent Endometrial Endometrioid Adenocarcinoma | Stage III Uterine Corpus Cancer AJCC v7 | Stage IIIA Uterine Corpus Cancer AJCC v7 | Stage IIIB Uterine Corpus Cancer AJCC v7 | Stage IIIC Uterine Corpus Cancer AJCC v7 | Stage IV Uterine Corpus Cancer AJCC... and other conditionsUnited States
-
Roswell Park Cancer InstituteAbbVieCompletedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | PSA Progression | Metastatic Prostate Carcinoma in the Soft Tissue | Castration Levels of Testosterone | Prostate Carcinoma...United States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Astellas Pharma Inc; Medivation, Inc.Active, not recruitingRecurrent Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Stage IIB Prostate CancerUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; Myriad Genetics, Inc.; Foundation Medicine, Inc.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Canada, Denmark, Germany, Italy, Netherlands, Norway, Spain, Argentina, Taiwan, France, Korea, Republic of, Brazil, Japan, Turkey, United Kingdom, Austria, Australia, Israel, Sweden
-
University of WashingtonJanssen Research & Development, LLCTerminatedCastration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Double-Negative Prostate CarcinomaUnited States
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States, Australia, Spain, United Kingdom, Denmark, Belgium, Slovakia, Finland, Italy, France, Sweden
-
Jonsson Comprehensive Cancer CenterGlaxoSmithKline; Novartis; Astellas Pharma Inc; Prostate Cancer Foundation; Medivation...Active, not recruitingProstate CancerUnited States
-
PfizerCompletedProstatic Neoplasms, Castration-ResistantUnited States
-
Institute of Cancer Research, United KingdomAstraZeneca; Astellas Pharma Inc; Prostate Cancer UKTerminatedMetastatic Castration Resistant Prostate CancerUnited Kingdom, Switzerland
-
zr Pharma & GmbHCompletedMetastatic Castration Resistant Prostate CancerUnited States
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Cancer of the ProstateSwitzerland